Impact of Exogenous Proteolytic Enzymes on Immunogenesis in Patients with Urogenital Infections
Abstract
The use of systemic enzyme therapy in combination with antibiotics in the treatment of urogenital chlamydia infection in patients of both sexes proved to improve the therapeutic efficacy and to reduce the risk of the side effects.
About the Authors
A. A. Khryanin
Novosibirsk State Medical University; Association of Obstetric Gynecologists and Dermatovenerologists
Russian Federation
Russian Federation
O. V. Reshetnikov
Research Institute of Therapy, Siberian Branch of Russian Academy of Medical Sciences
Russian Federation
Russian Federation
I. D. Safronov
Novosibirsk State Medical University; Scientific Centre of Clinical and Experimental Medicine, Siberian Branch of Russian Academy of Medical Sciences
Russian Federation
Russian Federation
References
1. Ющук Н. Д., Малиновский М. Ю., Сундуков А. В. Системная энзимотерапия (Вобэнзим, Флогэнзим) в комплексном лечении вирусных гепатитов. Эпидемиолог инфекц бол 2001; 2: 53-55.
2. Kleine M. W. Introduction to oral enzyme therapy. Int J Immunotherapy 1997; 13: 59-65.
3. Lorkowski G. Gastrointestinal absorption and biological activities of serine and cysteine proteases of animal and plant origin: review on absorption of serine and cysteine proteases // Int J Physiol Pathophysiol Pharmacol 2012; 4: 1: 10-27.
4. Biziulevicius G A. Where do the immunostimulatory effects of oral proteolytic enzymes ('systemic enzyme therapy') come from? Microbial proteolysis as a possible starting point. Med Hypotheses 2006; 67: 6: 1386-1388.
5. Энциклопедия лекарств. Реестр лекарственных средств России. Выпуск 9. М.: РЛС, 2002:902.
6. Молочков В. А., Гущин А. Е., Мугутдинова А. С., Балюра Е. В. Системная энзимо- и иммунотерапия хронического хламидийного простатита. Эффект фармакотер 2010; 1: 10-15.
7. Повышение эффективности и снижение побочных эффектов антибактериальной терапии методом системной энзимотерапии. Метод. реком. ДЗ Москвы. М.: 2005; 32.
8. Системная энзимотерапия. Практическое руководство для врачей / Под ред. В. А. Насоновой. СПб.: 1998; 32.
9. Minaev S.V., Obozin V.S., Barnash G.M., Obedin A.N. The influence of enzymes on adhesive processes in the abdominal cavity. Eur J Pediatr Surg 2009 Dec; 19: 6: 380-383.
10. Стернин Ю. И., Ремезов А. П., Кнорринг Г. Ю. Системная энзимотерапия - перспективный метод лечения в дерматовенерологии. Практ мед 2011; 2: 1-3.
11. Petru E., Stranz B., Petru C. Effects of proteolytic enzyme therapy with Wobe Mugos against chemotherapy-induced toxicity in breast cancer patients - results of a pilot study. Wien Med Wochenschr 2010 Nov; 160: 19-20: 513-516.
12. Sakalova A., Bock P.R., Dedik L. et al. Retrospective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma. Cancer Chemother Pharmacol 2001 Jul; 47: Suppl: S38-44.
13. Скрипкин Ю.К, Кубанова А.А, Аковбян В. А. и др. Проблема диагностики и лечения урогенитального хламидиоза в России. Антибиотики и химиотер 1996; 40: 5-8.
14. Mallinson H., Hopwood J., Skidmore S. et al. Provision of chlamydia testing in a nationwide service offering termination of pregnancy: with data capture to monitor prevalence of infection. Sex Transm Infect 2002; 78: 416-421.
15. Протокол ведения больных «Инфекции, передаваемые половым путем». «Урогенитальная хламидийная инфекция»/ Под ред. В. И. Кисиной. М.: Ньюдиамед. 2011. 164-191.
16. Workowski K.A., Berman S.; Centers for Disease Control and Prevention (CDC). Sexually Transmitted Diseases Treatment Guidelines, 2010. MMWR Recomm Rep. 2010; 59(RR-12): 1-10.
17. Lau C.Y., Qureshi A.K. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials // Sex. Transm. Dis 2002; 29: 9: 497-502.
18. Adimora A.A. Treatment of uncomplicated genital Chlamydia trachomatis infections in adults. Clin Infect Dis 2002; 35: S183-S186.
19. Schillinger J.A., Kissinger P., Calvet H. et al. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachoma tis infection among women: a randomized, controlled trial. Sex Transm Dis 2003; 30: 49-56.
20. Golden M.R., Whittington W.L., Handsfield H.H. et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med 2005; 352: 676-685.
21. Haggerty C., Gottlieb S., Taylor B. et al. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 2010; 201: Suppl 2: S134-155.
22. Oakeshott P., Kerry S., Aghaizu A. et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ 2010; 340: c1642.
23. Cohen C.R, Brunhman R.C. Pathogenesis of chlamydia induced pelvic inflammatory disease. Sex Transm Infect 1999; 75: 21-24.
Review
For citations:
Khryanin A.A., Reshetnikov O.V., Safronov I.D. Impact of Exogenous Proteolytic Enzymes on Immunogenesis in Patients with Urogenital Infections. Antibiot Khimioter = Antibiotics and Chemotherapy. 2012;57(9-10):25-31. (In Russ.)
Views:
312
Email this article 